Ispire's revenue slips 9.3% year on year as European rules bite; credit charge drives loss
The vaping hardware maker posted $27.5M in first-quarter fiscal 2027 revenue, with a $4.8M credit loss expense accounting for most of its $6.4M net loss.
Ispire Technology (Nasdaq: ISPR) said revenue for the three months to 30 September 2026 was $27.5M, 9.3% below the same quarter a year earlier. That implies a prior-year figure of roughly $30.3M. The company attributed the decline to softer demand in Europe, which it linked to stricter rules on vaping products. The material reviewed did not say which countries or product lines were most affected.
Against the prior quarter, the picture was better: revenue rose 3.2%. The results, announced on 9 November, cover the first quarter of the company's 2027 fiscal year.
Margins and cash flow moved in the right direction. Gross margin was 16.2%, and Adjusted EBITDA came in at $136,000, a small profit. The net loss was $6.4M, and the company's figures include a $4.8M credit loss expense, about three-quarters of the headline loss. Cash at quarter-end was $15.6M.
The summary reviewed contained no management commentary, no outlook and no breakdown of the credit charge. The cause of that expense, and whether it is likely to recur, therefore cannot be determined from the available information.
Why it matters
- Ispire links its year-on-year revenue decline to European regulation, so regulatory change is showing up in this company's reported sales.
- The $4.8M credit loss expense is the main reason the net loss sits so far from the near-breakeven Adjusted EBITDA. Its cause was not disclosed.
- With $15.6M in cash and no guidance in the material reviewed, the next set of results will show whether the sequential revenue gain holds.
Company's press release (SEC filing): Ispire Technology Inc. ↗
Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.